tm logo
Trademark Search
HEMGENIX

View On IC.GC.CA

HEMGENIX
REGISTERED

on 30 Nov 2022

Last Applicant/ Owned by

CSL BEHRING L.L.C.

1020 First AvenueKing of Prussia PA 19406

US

Serial Number

2019566 filed on 06th Feb 2020

Registration Number

TMA1153970 registered on 30th Nov 2022

Registration expiry Date

06th Feb 2030

Correspondent Address

SUITE 2600, 160 ELGIN STREETOTTAWA

ONTARIO

CA

K1P1C3

HEMGENIX

Trademark usage description

pharmaceutical products for the treatment of hemophilia; pharmaceutical preparations and human vaccines for use in gene therapy and cell therapy; biol Read More

Classification Information

Class [005]
Pharmaceutical products for the treatment of hemophilia; pharmaceutical preparations and human vaccines for use in gene therapy and cell therapy; biological preparations for use in medical and clinical gene therapy and cell therapy for the treatment of hemophilia; clinical medical reagents for use in gene therapy, gene diagnosis and gene testing

Classification kind code

11

Mark Details

Serial Number

2019566

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 48
on 24th Nov 2021		Agent Changed
Submitted for opposition 22
on 26th Jul 2021		Search Recorded
Submitted for opposition 20
on 26th Jul 2021		Examiner's First Report
Submitted for opposition 223
on 26th Jul 2021		Total Provisional Refusal
Submitted for opposition 256
on 26th Jan 2021		Notification of Possible Opposition Sent
Submitted for opposition 257
on 26th Mar 2020		Designation Notification - Madrid Protocol
Submitted for opposition 1
on 25th Mar 2020		Created
Submitted for opposition 31
on 25th Mar 2020		Formalized
Submitted for opposition 30
on 06th Feb 2020		Filed
Submitted for opposition 228
on 06th Feb 2020		International Registration